StockTipsArenaBeta

BUY RPG Life Sciences Limited — ICICI Securities

BUYRPG Life Sciences Limited
RPG Life Sciences share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)4 Sept 2026via Institutional / Brokerage Research

Entry₹2,721.6Inferred
Target₹3,205
Total upside +17.76%
Stop lossNot given
CMP₹2,780.2Just now
Active+2.15%+15.28%upside left 11 mo left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch RPGLIFE for new buy/sell callsGet alertsSee 1 other Long-term call on RPGLIFESee 212 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 4:04 pm IST
13 supporting4 neutral0 opposing
Supports the BUY call (13)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·21 Oct · yesterday

RPG Life Sciences Ltd announced the completion of the acquisition of Actis Generics Private Limited. Actis is now a subsidiary of RPG Life Sciences and a wholly-owned subsidiary of RPG Active Pharma L

BSE · Company Update·24 Sept · 4w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·20 Aug · 2mo ago

Neutral / worth noting (4)

RPG Life Sciences' subsidiary, RPG Active Pharma Limited, has approved a Scheme of Amalgamation with its wholly-owned subsidiary, Actis Generics Private Limited. The scheme is subject to regulatory an

BSE · Company Update·26 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on RPG Life Sciences

All analyst calls on RPG Life Sciences

More from ICICI Securities

Every call and its outcome